Search results
Oct 30, 2021 · Mounting evidence indicates that vitamin C has the potential to be a potent anti-cancer agent when administered intravenously and in high doses (high-dose IVC). Early phase clinical trials have confirmed safety and indicated efficacy of IVC in eradicating tumour cells of various cancer types.
- Franziska Böttger, Andrea Vallés-Martí, Loraine Cahn, Connie R. Jimenez
- 2021
Aug 26, 2021 · Infusions are a way to deliver drugs and medications directly into the bloodstream instead of taking them as pills or liquids. Infusion treatments are commonly used to deliver chemotherapy, immunotherapy, and targeted therapy to treat cancer. Infusion therapies are liquids usually given from a plastic bag filled with medicine that's attached to ...
People also ask
Can high-dose intravenous vitamin C be combined with cytotoxic chemotherapy?
Is vitamin C a chemo treatment for cisplatin ineligible bladder cancer?
Can high-dose IVC be combined with cytotoxic chemotherapy?
Is high-dose IVC a good anti-cancer agent?
Apr 30, 2018 · INTRODUCTION. Historically, Cameron and Campbell 1 and Cameron and Pauling 2 investigated oral and intravenous vitamin C (IV C) treatment in patients with advanced malignancy. . Phase i trials in which IV C doses of 75–220 g (up to 1.5 g/kg or 110 mg/m 2) were given to patients with advanced malignancies alone and in combination with chemotherapy demonstrated both safety and tolerability ...
- E. Klimant, H. Wright, D. Rubin, D. Seely, M. Markman
- 10.3747/co.25.3790
- 2018
- Curr Oncol. 2018 Apr; 25(2): 139-148.
Aug 23, 2018 · Abstract. The use of intravenous vitamin C (IVC) for cancer therapy has long been an area of intense controversy. Despite this, high dose IVC has been administered for decades by complementary health care practitioners and physicians, with little evidence base resulting in inconsistent clinical practice. In this review we pose a series of ...
- Anitra C. Carr, John Cook
- 10.3389/fphys.2018.01182
- 2018
- Front Physiol. 2018; 9: 1182.
Jan 11, 2021 · Keywords: vitamin C, plasma, tumor, colorectal cancer, normal mucosa, tumor hypoxia, hypoxia-inducible factor. The use of high dose vitamin C (ascorbate) infusions as a complementary therapy for cancer is widespread ( 1 ), despite a lack of robust evidence for efficacy.
- Gabi U Dachs, Jamish Gandhi, Christina Wohlrab, Anitra C Carr, Helen R Morrin, Juliet M Pullar, Simo...
- 10.3389/fonc.2020.600715
- 2021
- Front Oncol. 2020; 10: 600715.
Apr 7, 2015 · Background Biological and some clinical evidence suggest that high-dose intravenous vitamin C (IVC) could increase the effectiveness of cancer chemotherapy. IVC is widely used by integrative and complementary cancer therapists, but rigorous data are lacking as to its safety and which cancers and chemotherapy regimens would be the most promising to investigate in detail. Methods and Findings We ...
Overview. This cancer information summary provides an overview of the use of intravenous (IV) vitamin C (also known as ascorbate or L- ascorbic acid) as a treatment for people with cancer. This summary includes a brief history of early clinical trials of the use of IV vitamin C; reviews of laboratory, animal, and human studies; and current ...
